Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 4
1993 3
1994 3
1995 8
1996 6
1997 5
1998 13
1999 27
2000 42
2001 41
2002 71
2003 83
2004 70
2005 91
2006 74
2007 72
2008 89
2009 63
2010 69
2011 71
2012 91
2013 75
2014 83
2015 70
2016 77
2017 57
2018 52
2019 59
2020 66
2021 55
2022 65
2023 51
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

1,569 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of prescriptions from tertiary care hospitals across India for deviations from treatment guidelines & their potential consequences.
Shetty Y, Kamat S, Tripathi R, Parmar U, Jhaj R, Banerjee A, Balakrishnan S, Trivedi N, Chauhan J, Chugh PK, Tripathi CD, Badyal DK, Solomon L, Kaushal S, Gupta K, Jayanthi M, Jeevitha G, Chatterjee S, Samanta K, Desai C, Shah S, Medhi B, Joshi R, Prakash A, Gupta P, Roy A, Chandy S, Ranjalkar J, Bright HR, Dikshit H, Mishra H, Roy SS, Kshirsagar N. Shetty Y, et al. Indian J Med Res. 2023 Mar 23. doi: 10.4103/ijmr.ijmr_2309_22. Online ahead of print. Indian J Med Res. 2023. PMID: 38528817 Free article.
Two thousand one hundred and seventy-one prescriptions had deviations, of which 475 (21.9%) had unacceptable deviations with pantoprazole (n=54), rabeprazole+domperidone (n=35) and oral enzyme preparations (n=24) as the most frequently prescribed drugs and upper respirator …
Two thousand one hundred and seventy-one prescriptions had deviations, of which 475 (21.9%) had unacceptable deviations with pantoprazole (n …
A comprehensive review on potential drug-drug interactions of proton pump inhibitors with antidiabetic drugs metformin and DPP-4 inhibitors.
Tasnim J, Hashim NM, Han HC. Tasnim J, et al. Cell Biochem Funct. 2024 Mar;42(2):e3967. doi: 10.1002/cbf.3967. Cell Biochem Funct. 2024. PMID: 38480622 Review.
This review article mainly focused on evaluating the potential drug-drug interactions (DDIs) between PPIs (i.e. esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole) with metformin and PPIs with DPP-4 inhibitors. The findings demonstrated the existence of …
This review article mainly focused on evaluating the potential drug-drug interactions (DDIs) between PPIs (i.e. esomeprazole, lansoprazole, …
Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study.
Li Y, Zheng M, Wang Y, Xu G, He Y, Wu Y, Wang X, Liu Y, Jiang Y, Liu X, Meng Y, Yap Y, Zhu S, He C, Zhou B. Li Y, et al. Front Pharmacol. 2024 Feb 13;15:1275740. doi: 10.3389/fphar.2024.1275740. eCollection 2024. Front Pharmacol. 2024. PMID: 38464723 Free PMC article.
The experimental group received THLY granules combined with rabeprazole capsules. The control group received THLY granule placebo combined with rabeprazole capsules. ...
The experimental group received THLY granules combined with rabeprazole capsules. The control group received THLY granule placebo com …
Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori: A randomized clinical trial.
Seddik H, Benass J, Berrag S, Sair A, Berraida R, Boutallaka H. Seddik H, et al. World J Gastroenterol. 2024 Feb 14;30(6):556-564. doi: 10.3748/wjg.v30.i6.556. World J Gastroenterol. 2024. PMID: 38463026 Free PMC article. Clinical Trial.
METHODS: This open-label prospective study randomized 328 patients with confirmed H. pylori infection into three groups (1:1:1): The first group received quadruple therapy consisting of twice-daily (bid) omeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg and metronidazole 5 …
METHODS: This open-label prospective study randomized 328 patients with confirmed H. pylori infection into three groups (1:1:1): The first g …
The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan.
Tai WC, Wu IT, Wang HM, Huang PY, Yao CC, Wu CK, Yang SC, Liang CM, Hsu PI, Chuah SK. Tai WC, et al. J Microbiol Immunol Infect. 2024 Mar 4:S1684-1182(24)00046-X. doi: 10.1016/j.jmii.2024.02.009. Online ahead of print. J Microbiol Immunol Infect. 2024. PMID: 38461114 Free article.
Patients were assigned to either a 14-day esomeprazole-based HDDT (EA-14; esomeprazole 40 mg t.i.d. and amoxicillin 750 mg q.i.d. for 14 days, n = 173) or a 14-day rabeprazole-based HDDT (RA-14; rabeprazole 20 mg and amoxicillin 750 mg q.i.d. for 14 days, n = 173). …
Patients were assigned to either a 14-day esomeprazole-based HDDT (EA-14; esomeprazole 40 mg t.i.d. and amoxicillin 750 mg q.i.d. for 14 day …
Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials.
Li X, Liu Y, Wang M, Gao L, Liu J, Zhang H, Wu M, Chen H, Lou J, Wang J, Chen J, Geng G, Ma Z, Ding Y. Li X, et al. Lancet Infect Dis. 2024 Feb 12:S1473-3099(24)00003-3. doi: 10.1016/S1473-3099(24)00003-3. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38359854
Single doses of rifasutenizol (50-1000 mg) and multiple doses of rifasutenizol (200 mg to 600 mg, twice a day), either as monotherapy or co-administered with rabeprazole and amoxicillin, showed favourable safety and tolerability profiles. ...In trial 4, H pylori eradicatio …
Single doses of rifasutenizol (50-1000 mg) and multiple doses of rifasutenizol (200 mg to 600 mg, twice a day), either as monotherapy or co- …
Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis.
Zhuang Q, Chen S, Zhou X, Jia X, Zhang M, Tan N, Chen F, Zhang Z, Hu J, Xiao Y. Zhuang Q, et al. Am J Gastroenterol. 2024 Mar 22. doi: 10.14309/ajg.0000000000002714. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38345252
Studies included incorporated 3 P-CAB (vonoprazan, tegoprazan, and keverprazan) and 6 PPI (lansoprazole, esomeprazole, omeprazole, rabeprazole extended-release (ER), pantoprazole, and dexlansoprazole). ...
Studies included incorporated 3 P-CAB (vonoprazan, tegoprazan, and keverprazan) and 6 PPI (lansoprazole, esomeprazole, omeprazole, rabepr
Therapeutic Evaluation of Bifidobacterium animalis subsp. lactis MH-02 as an Adjunctive Treatment in Patients with Reflux Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Gan L, Wang Y, Huang S, Zheng L, Feng Q, Liu H, Liu P, Zhang K, Chen T, Fang N. Gan L, et al. Nutrients. 2024 Jan 24;16(3):342. doi: 10.3390/nu16030342. Nutrients. 2024. PMID: 38337627 Free PMC article. Clinical Trial.
A total of 110 eligible RE patients were recruited and randomly assigned to the placebo and probiotic groups. All patients were treated with rabeprazole tablets and simultaneously received either Bifidobacterium animalis subsp. lactis MH-02 or placebo for 8 weeks. ...
A total of 110 eligible RE patients were recruited and randomly assigned to the placebo and probiotic groups. All patients were treated with …
High frequency electrocoagulation resection effect analysis and prognosis observation in the treatment of patients with gastric polyps under painless gastroscopy.
Chen X, Zhang D, Chen M. Chen X, et al. Medicine (Baltimore). 2024 Feb 9;103(6):e37027. doi: 10.1097/MD.0000000000037027. Medicine (Baltimore). 2024. PMID: 38335390 Free PMC article. Clinical Trial.
Control group was also given basic treatment drugs for 8 weeks, and then received high-frequency electrocoagulation resection under ordinary gastroscope. The patients in both groups were given rabeprazole sodium enteric coated capsules for 4 weeks. The improvement of sympt …
Control group was also given basic treatment drugs for 8 weeks, and then received high-frequency electrocoagulation resection under ordinary …
1,569 results